Physician profile
Ron Adduru
NPI 1588394993
$3,338.94
in general payments reported to CMS, 2019-2025
10 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $235 · 2024: $1,937 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,403 · Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,403.08 |
| Travel and Lodging | $751.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,599.45 | 2024 | |
| Stryker Corporation | $1,146.58 | 2022-2025 | Augment Injectable, Hoffmann, Infinity Adaptis |
| Paratek Pharmaceuticals, INC. | $180.34 | 2025 | Nuzyra |
| Cgg Medical INC | $141.50 | 2025 | |
| Organogenesis INC. | $118.41 | 2024 | Nushield |
| Trilliant Surgical LLC. | $44.84 | 2025 | Minimally Invasive Bunion Plate, Left |
| Medinc of Texas | $34.26 | 2024 | |
| Coastal Medical Technologies LLC | $29.69 | 2025 | |
| Treace Medical Concepts, INC. | $23.97 | 2024 | |
| Kerecis Limited | $19.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Adduru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.